Friedreich Ataxia Scientific News
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Wednesday, March 6, 2024
Vestibular Pathology as Early Finding of Friedreich's Ataxia in a 16 Years Old Woman
›
Fernández AG. Vestibular Pathology as Early Finding of Friedreich's Ataxia in a 16 Years Old Woman. Indian J Otolaryngol Head Neck Surg....
Saturday, March 2, 2024
Frataxin Traps Low Abundance Quaternary Structure to Stimulate Human Fe-S Cluster Biosynthesis
›
1. Cory S, Lin C-W, Havens S, Patra S, Putnam C, Shirzadeh M, et al. Frataxin Traps Low Abundance Quaternary Structure to Stimulate Human Fe...
Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia
›
Lynch, D.R., Subramony, S., Lin, K.Y. et al. Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia. Pediatr Cardiol (2...
Friday, March 1, 2024
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updat
›
CAMBRIDGE, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a ...
After pair of failures, PTC finds a path through FDA jungle for Friedreich ataxia med
›
https://www.fiercebiotech.com. By Annalee Armstrong; Mar 1, 2024. In a fourth-quarter earnings update Thursday afternoon, PTC executives bri...
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
›
SOUTH PLAINFIELD, N.J., Feb. 29, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. PTC had a Type C meeting with the FDA in the first quarter of 2...
Monday, February 26, 2024
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences
›
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Bios...
Sunday, February 25, 2024
Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort
›
Shen MM, Rummey C, Lynch DR. Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort. Ann Clin Transl Neurol. 2024 ...
Thursday, February 22, 2024
Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Friedreich's ataxia (FRDA) patients with homozygous GAA repeat expansion in FXN gene
›
Ahmad I, Kapoor H, Srivastava AK, Faruq M. Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Fried...
Wednesday, February 21, 2024
Union Register of medicinal products for human use: (2024)975 of 09 Feb 2024 Skyclarys
›
https://ec.europa.eu/health/documents/community-register/2024/20240209161576/dec_161576_es.pdf https://ec.europa.eu/health/documents/commu...
‹
›
Home
View web version